Literature DB >> 6824496

Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia.

J P Kane, G C Chen, R L Hamilton, D A Hardman, M J Malloy, R J Havel.   

Abstract

We used the low molecular weight form of apolipoprotein B (B-48) as a marker for the identification of remnant particles formed from chylomicrons in the plasma of patients with familial dysbetalipoproteinemia. In the serum of patients fasted 14 hours, the d less than 1.006 g/cm3 lipoproteins of prebeta mobility, separated by starch block electrophoresis, contained only the primary hepatogenous species of apolipoprotein B (B-100), and their lipid composition resembled that of normal prebeta very low density lipoproteins. In contrast, the fraction with beta mobility contained both the B-48 and B-100 proteins; the B-48 protein was found primarily among the largest particles. All fractions of beta mobility were greatly enriched with cholesteryl esters. The beta fraction thus contains remnant particles which appear to originate both from chylomicrons and hepatogenous very low density lipoproteins. It appears that these remnant particles share a common removal mechanism which is impaired in familial dysbetalipoproteinemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824496     DOI: 10.1161/01.atv.3.1.47

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  18 in total

Review 1.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

Review 2.  Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids.

Authors:  G J Nelson; R G Ackman
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

3.  Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins.

Authors:  S D Krasinski; J S Cohn; E J Schaefer; R M Russell
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  Effect of dietary restriction on the plasma apolipoprotein pattern in cholesterol-fed rabbits.

Authors:  G Corraze; C Lacombe; M Nibbelink
Journal:  Lipids       Date:  1985-11       Impact factor: 1.880

5.  Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism.

Authors:  M S Weintraub; R Zechner; A Brown; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

6.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

8.  Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.

Authors:  R W Mahley; K H Weisgraber; M M Hussain; B Greenman; M Fisher; T Vogel; M Gorecki
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

9.  Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein.

Authors:  A Tall; E Granot; R Brocia; I Tabas; C Hesler; K Williams; M Denke
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

10.  Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.

Authors:  R W Milne; P K Weech; L Blanchette; J Davignon; P Alaupovic; Y L Marcel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.